Medication info

Creecool Powder

Prescription medicationOralApproval withdrawn
Ingredient · strength
Polyethylene Glycol 3350›50gAnhydrous Sodium Sulfate›3.75gSodium Chloride›1.3455gPotassium Chloride›0.5075gAscorbic Acid›2.35gSodium Ascorbate›2.95g
Manufacturer / importer
Hanook Pharma Co., Ltd.
Appearance
Product A: A white or light yellow powder with a lemon scent, contained in an aluminum foil pouch. Product B: A white crystalline or crystalline powder without an odor and with a sour taste, contained in an aluminum foil pouch.
Packaging
1) (Product A: 112.803g/package, Product B: 10.6g/package) × 2, bottle (1000mL) 2) (Product A: 56.402g/package, Product B: 5.3g/package) × 4, bottle (500mL)
Approval status
Approval withdrawn

MFDS item code 201309004 · Notified 2013.08.27

This product's status changed to Approval withdrawn on 2025.04.02. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improved preparation for examination through bowel cleansing before colon examination
Who takes it
Adults
Adult dose
Adults 18 years of age and older: take as a split-dose or non-split-dose regimen as follows. Split-dose regimen: On the evening before colonoscopy, drink 1L of reconstituted solution over 1 hour (one 250mL cup every 15 minutes), then drink an additional 500ml of water. The next morning, drink 1L of reconstituted solution over 1 hour, then drink an additional 500ml of water. This process must be completed at least 1 hour before the start of colonoscopy. Non-split-dose (evening) regimen: At approximately 6 p.m. on the evening before colonoscopy, drink 1L of reconstituted solution over 1 hour (one 250mL cup every 15 minutes); 1.5 hours later, drink 1L of reconstituted solution over 1 hour, then drink an additional 1L of water. Split-dose regimen: On the evening before colonoscopy, drink 1L of reconstituted solution (reconstitute the 500mL solution * 2 times) over 1 hour (one 250mL cup every 15 minutes), then drink an additional 500mL of water. The next morning, drink 1L of reconstituted solution (reconstitute the 500mL solution * 2 times) over 1 hour, then drink an additional 500mL of water. This process must be completed at least 1 hour before the start of colonoscopy. Non-split-dose (evening) regimen: At approximately 6 p.m. on the evening before colonoscopy, drink 1L of reconstituted solution (reconstitute the 500mL solution * 2 times) over 1 hour (one 250mL cup every 15 minutes); 1.5 hours later, drink 1L of reconstituted solution (reconstitute the 500mL solution * 2 times) over 1 hour, then drink an additional 1L of water.

Ingredients

Manufacturer
Hanook Pharma Co., Ltd.

Efficacy & effects

Improved preparation for examination through bowel cleansing before colon examination

View approved original text

Used to cleanse the bowels before undergoing a colonoscopy or X-ray examination.

How to take

Adult dose

Adults 18 years of age and older: take as a split-dose or non-split-dose regimen as follows. Split-dose regimen: On the evening before colonoscopy, drink 1L of reconstituted solution over 1 hour (one 250mL cup every 15 minutes), then drink an additional 500ml of water. The next morning, drink 1L of reconstituted solution over 1 hour, then drink an additional 500ml of water. This process must be completed at least 1 hour before the start of colonoscopy. Non-split-dose (evening) regimen: At approximately 6 p.m. on the evening before colonoscopy, drink 1L of reconstituted solution over 1 hour (one 250mL cup every 15 minutes); 1.5 hours later, drink 1L of reconstituted solution over 1 hour, then drink an additional 1L of water. Split-dose regimen: On the evening before colonoscopy, drink 1L of reconstituted solution (reconstitute the 500mL solution * 2 times) over 1 hour (one 250mL cup every 15 minutes), then drink an additional 500mL of water. The next morning, drink 1L of reconstituted solution (reconstitute the 500mL solution * 2 times) over 1 hour, then drink an additional 500mL of water. This process must be completed at least 1 hour before the start of colonoscopy. Non-split-dose (evening) regimen: At approximately 6 p.m. on the evening before colonoscopy, drink 1L of reconstituted solution (reconstitute the 500mL solution * 2 times) over 1 hour (one 250mL cup every 15 minutes); 1.5 hours later, drink 1L of reconstituted solution (reconstitute the 500mL solution * 2 times) over 1 hour, then drink an additional 1L of water.

Precautions

This medication may rarely cause systemic tonic-clonic seizures even in patients without a history of seizures, so patients with electrolyte imbalances or those taking corresponding high-risk medications should exercise caution. It should not be administered to patients with serious gastrointestinal diseases such as bowel obstruction, intestinal perforation, toxic colitis, etc., and should be used cautiously in patients with severe ulcerative colitis. The artificial sweetener aspartame included in this medication breaks down into phenylalanine, so it should not be taken by patients with phenylketonuria. Patients who have hypersensitivity to this medication or its components, have gastrointestinal obstruction, perforation, dehydration, severe heart failure, active cancer, severe mucosal injury diseases, etc., should not take this medication. Elderly patients, frail patients, patients with severe constipation or bowel stenosis, and patients with significantly impaired kidney function should use this medication cautiously. This medication can cause side effects such as hunger, hypokalemia, headache, dizziness, abdominal pain, nausea, vomiting, abdominal distension, fatigue, and more. If unusual symptoms occur, they should contact healthcare professionals immediately. Particularly in elderly patients, serious side effects such as gastrointestinal bleeding, esophageal perforation, and acute pulmonary edema have been reported, so caution is required. While administering this medication, the patient's bowel movement status should be closely monitored, and if abdominal distension or pain worsens, the rate of administration should be slowed or stopped, and appropriate examination should be performed. If symptoms of fluid or electrolyte imbalance occur, blood tests should be conducted to confirm the condition and appropriate treatment should be given. Patients with heart disease or a high risk of electrolyte abnormalities should undergo ECG and kidney function tests, and assessments are recommended before and after a colonoscopy. This medication may induce diarrhea, so adequate hydration is essential. The risk of bowel mucosal damage increases when used with irritant laxatives, so co-administration is not recommended. It is desirable to fast for at least 1 hour before administration and not to consume solid food during administration. The effects of this medication on driving or machine operation are not known, but caution is advised if unusual symptoms occur. This medication may interfere with the absorption of other oral medications, so it is advisable to avoid taking other medications within 1 hour before and after administration. Pregnant or breastfeeding women should only use this medication if diagnostic benefits outweigh the risks, as safety has not been established. Children should not be administered this medication, as its safety and effectiveness have not been established, and elderly patients may be more sensitive to the drug, so caution is needed. In the case of overdose, dehydration and severe electrolyte abnormalities may occur, so immediate medical attention is necessary for appropriate treatment. This medication should not have other ingredients or fragrances added before administration, and should be taken immediately after dissolving in water; any remaining solution should be discarded within 24 hours. Store in a place out of reach of children; the prepared solution should be covered and refrigerated, and must not be transferred to other containers.

Side effects

  • Hunger
  • hypophosphatemia
  • hypokalemia
  • sleep disturbances
  • dizziness
  • headache
  • abdominal pain
  • colicky pain
  • nausea
  • abdominal distension
Show 47 more
  • anal discomfort
  • vomiting
  • dyspepsia
  • dysphagia
  • lethargy
  • thirst
  • tremor
  • malaise
  • decreased serum bicarbonate
  • decreased serum calcium
  • hypercalcemia
  • decreased or increased serum chloride
  • increased serum phosphate
  • liver dysfunction
  • rash
  • urticaria
  • rhinitis
  • dermatitis
  • edema
  • anaphylactic-like reaction
  • gastric mucosal damage
  • upper gastrointestinal bleeding
  • esophageal perforation
  • cardiac asystole
  • acute pulmonary edema
  • tachycardia
  • palpitations
  • hypertension
  • arrhythmia
  • atrial fibrillation
  • peripheral edema
  • syncope
  • dehydration
  • anaphylactic reaction
  • pruritus
  • lip swelling
  • tongue swelling
  • facial edema
  • dyspnea
  • chest tightness
  • throat tightness
  • fever
  • chills
  • tremors
  • seizures
  • renal dysfunction
  • renal failure

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is susceptible to air and moisture, so it should be kept in a tightly sealed container. Also, it should be stored in a cool place, and it is important to maintain a temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

Product A: A white or light yellow powder with a lemon scent, contained in an aluminum foil pouch. Product B: A white crystalline or crystalline powder without an odor and with a sour taste, contained in an aluminum foil pouch.

Package unit

1) (Product A: 112.803g/package, Product B: 10.6g/package) × 2, bottle (1000mL) 2) (Product A: 56.402g/package, Product B: 5.3g/package) × 4, bottle (500mL)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.